type 2a Search Results


90
ATCC 40341 u s pat
40341 U S Pat, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/40341 u s pat/product/ATCC
Average 90 stars, based on 1 article reviews
40341 u s pat - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

91
Alomone Labs l type ca channel
L Type Ca Channel, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l type ca channel/product/Alomone Labs
Average 91 stars, based on 1 article reviews
l type ca channel - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

93
Alomone Labs kchip2
Localization and expression of potassium channel-associated proteins in mouse atrial myocytes. A. Immunofluorescence images showing membrane localization and expression of Kv4.3, Kv4.2, <t>KChIP2,</t> Kv1.5, and Kir2.1 in atrial cardiomyocytes from LFD and HFD groups. Scale bar, 100 μm. B. Representative Western blotting images and densitometric quantification of Kv4.3, Kv4.2, KChIP2, Kv1.5, and Kir2.1 protein expression in atrial cardiomyocytes from LFD and HFD mice. LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD ( n = 3). ns, not significant; * p < 0.05, ** p < 0.01 vs. LFD group.
Kchip2, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kchip2/product/Alomone Labs
Average 93 stars, based on 1 article reviews
kchip2 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

91
ATCC 40330 u s pat
Localization and expression of potassium channel-associated proteins in mouse atrial myocytes. A. Immunofluorescence images showing membrane localization and expression of Kv4.3, Kv4.2, <t>KChIP2,</t> Kv1.5, and Kir2.1 in atrial cardiomyocytes from LFD and HFD groups. Scale bar, 100 μm. B. Representative Western blotting images and densitometric quantification of Kv4.3, Kv4.2, KChIP2, Kv1.5, and Kir2.1 protein expression in atrial cardiomyocytes from LFD and HFD mice. LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD ( n = 3). ns, not significant; * p < 0.05, ** p < 0.01 vs. LFD group.
40330 U S Pat, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/40330 u s pat/product/ATCC
Average 91 stars, based on 1 article reviews
40330 u s pat - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

94
TargetMol inos antibody
Figure 7. Effects of CBD, S-88745 and S-92153 on the expression of <t>iNOS</t> <t>and</t> <t>COX-2</t> induced by LPS. In addition to an untreated control group and the LPS−treated group, RAW264.7 cells pretreated with CBD, S-88745 and S-92153 at 0.04, 0.4, and 4 µM for 1.5 h, and then treated all groups with LPS, except the control group for 20 h. The levels of iNOS and COX-2 in the culture supernatants of RAW264.7 macrophages were then detected by western blot. (A) iNOS and COX-2 protein expression levels. (B) Relative ration analysis of iNOS expression. (C) Relative ration analysis of COX-2 expression. The experiments were repeated three times. Each bar illustrates the average ± standard deviation (SD) counted from three experiments. p < 0.05 was considered statistically significant. * p < 0.05 compared to the LPS−treated group; ** p < 0.01 compared to the LPS−treated group; *** p < 0.001 compared to the LPS−treated group; **** p < 0.0001 compared to the LPS−treated group; # p < 0.0001 compared to the control group.
Inos Antibody, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inos antibody/product/TargetMol
Average 94 stars, based on 1 article reviews
inos antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

92
Miltenyi Biotec ccr2 pe
Figure 7. Effects of CBD, S-88745 and S-92153 on the expression of <t>iNOS</t> <t>and</t> <t>COX-2</t> induced by LPS. In addition to an untreated control group and the LPS−treated group, RAW264.7 cells pretreated with CBD, S-88745 and S-92153 at 0.04, 0.4, and 4 µM for 1.5 h, and then treated all groups with LPS, except the control group for 20 h. The levels of iNOS and COX-2 in the culture supernatants of RAW264.7 macrophages were then detected by western blot. (A) iNOS and COX-2 protein expression levels. (B) Relative ration analysis of iNOS expression. (C) Relative ration analysis of COX-2 expression. The experiments were repeated three times. Each bar illustrates the average ± standard deviation (SD) counted from three experiments. p < 0.05 was considered statistically significant. * p < 0.05 compared to the LPS−treated group; ** p < 0.01 compared to the LPS−treated group; *** p < 0.001 compared to the LPS−treated group; **** p < 0.0001 compared to the LPS−treated group; # p < 0.0001 compared to the control group.
Ccr2 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ccr2 pe/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
ccr2 pe - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

92
Miltenyi Biotec anti human ccr2 cd192 pe vio770
Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of <t>CCR2</t> + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).
Anti Human Ccr2 Cd192 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human ccr2 cd192 pe vio770/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
anti human ccr2 cd192 pe vio770 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

90
ProSci Incorporated anti protein kinase r anti pkr antibodies
Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of <t>CCR2</t> + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).
Anti Protein Kinase R Anti Pkr Antibodies, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti protein kinase r anti pkr antibodies/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
anti protein kinase r anti pkr antibodies - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

92
Miltenyi Biotec anti ccr2 apc
Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of <t>CCR2</t> + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).
Anti Ccr2 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ccr2 apc/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
anti ccr2 apc - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
ATCC 40338 u s pat
Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of <t>CCR2</t> + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).
40338 U S Pat, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/40338 u s pat/product/ATCC
Average 93 stars, based on 1 article reviews
40338 u s pat - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
CoaChrom Diagnostica GmbH vwd type 2 a patient plasma
Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of <t>CCR2</t> + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).
Vwd Type 2 A Patient Plasma, supplied by CoaChrom Diagnostica GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vwd type 2 a patient plasma/product/CoaChrom Diagnostica GmbH
Average 90 stars, based on 1 article reviews
vwd type 2 a patient plasma - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
HUYGEN ophthalmological findings in usher syndrome type 2a
Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of <t>CCR2</t> + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).
Ophthalmological Findings In Usher Syndrome Type 2a, supplied by HUYGEN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ophthalmological findings in usher syndrome type 2a/product/HUYGEN
Average 90 stars, based on 1 article reviews
ophthalmological findings in usher syndrome type 2a - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Localization and expression of potassium channel-associated proteins in mouse atrial myocytes. A. Immunofluorescence images showing membrane localization and expression of Kv4.3, Kv4.2, KChIP2, Kv1.5, and Kir2.1 in atrial cardiomyocytes from LFD and HFD groups. Scale bar, 100 μm. B. Representative Western blotting images and densitometric quantification of Kv4.3, Kv4.2, KChIP2, Kv1.5, and Kir2.1 protein expression in atrial cardiomyocytes from LFD and HFD mice. LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD ( n = 3). ns, not significant; * p < 0.05, ** p < 0.01 vs. LFD group.

Journal: Channels

Article Title: Association of the chemerin-CMKLR1 with atrial potassium current dysregulation and atrial fibrillation in obese mice

doi: 10.1080/19336950.2025.2611704

Figure Lengend Snippet: Localization and expression of potassium channel-associated proteins in mouse atrial myocytes. A. Immunofluorescence images showing membrane localization and expression of Kv4.3, Kv4.2, KChIP2, Kv1.5, and Kir2.1 in atrial cardiomyocytes from LFD and HFD groups. Scale bar, 100 μm. B. Representative Western blotting images and densitometric quantification of Kv4.3, Kv4.2, KChIP2, Kv1.5, and Kir2.1 protein expression in atrial cardiomyocytes from LFD and HFD mice. LFD, low-fat diet; HFD, high-fat diet. Data are presented as mean ± SD ( n = 3). ns, not significant; * p < 0.05, ** p < 0.01 vs. LFD group.

Article Snippet: Primary antibodies diluted in blocking buffer were applied overnight at 4°C as follows: resistin (1:1,000; Abcam, USA), chemerin (1:1,000; Abcam, USA), leptin (1:1,000; Abcam, USA), CMKLR1 (1:1,000; InvitrogenTM, USA), Kv4.3 (1:1,000; Alomone Labs, Israel), Kv4.2 (1:1,000; Alomone Labs, Israel), KChIP2 (1:1,000; Alomone Labs, Israel), Kv1.5 (1:1,000; Alomone Labs, Israel), Kir2.1 (1:1,000; Alomone Labs, Israel), β-Tubulin (1:1,000; Abcam, USA).

Techniques: Expressing, Immunofluorescence, Membrane, Western Blot

Figure 7. Effects of CBD, S-88745 and S-92153 on the expression of iNOS and COX-2 induced by LPS. In addition to an untreated control group and the LPS−treated group, RAW264.7 cells pretreated with CBD, S-88745 and S-92153 at 0.04, 0.4, and 4 µM for 1.5 h, and then treated all groups with LPS, except the control group for 20 h. The levels of iNOS and COX-2 in the culture supernatants of RAW264.7 macrophages were then detected by western blot. (A) iNOS and COX-2 protein expression levels. (B) Relative ration analysis of iNOS expression. (C) Relative ration analysis of COX-2 expression. The experiments were repeated three times. Each bar illustrates the average ± standard deviation (SD) counted from three experiments. p < 0.05 was considered statistically significant. * p < 0.05 compared to the LPS−treated group; ** p < 0.01 compared to the LPS−treated group; *** p < 0.001 compared to the LPS−treated group; **** p < 0.0001 compared to the LPS−treated group; # p < 0.0001 compared to the control group.

Journal: Antioxidants (Basel, Switzerland)

Article Title: Structural Optimization of Cannabidiol as Multifunctional Cosmetic Raw Materials.

doi: 10.3390/antiox12020314

Figure Lengend Snippet: Figure 7. Effects of CBD, S-88745 and S-92153 on the expression of iNOS and COX-2 induced by LPS. In addition to an untreated control group and the LPS−treated group, RAW264.7 cells pretreated with CBD, S-88745 and S-92153 at 0.04, 0.4, and 4 µM for 1.5 h, and then treated all groups with LPS, except the control group for 20 h. The levels of iNOS and COX-2 in the culture supernatants of RAW264.7 macrophages were then detected by western blot. (A) iNOS and COX-2 protein expression levels. (B) Relative ration analysis of iNOS expression. (C) Relative ration analysis of COX-2 expression. The experiments were repeated three times. Each bar illustrates the average ± standard deviation (SD) counted from three experiments. p < 0.05 was considered statistically significant. * p < 0.05 compared to the LPS−treated group; ** p < 0.01 compared to the LPS−treated group; *** p < 0.001 compared to the LPS−treated group; **** p < 0.0001 compared to the LPS−treated group; # p < 0.0001 compared to the control group.

Article Snippet: IL‐6 kits were bought from Elab‐ science (Elabscience, Wuhan, China). iNOS antibody and COX‐2 antibody were pur‐ chased from Signalway Antibody (Signalway Antibody, College Park, MA, USA) CBD and the hit compounds were purchased from TargetMol (TargetMol, Shanghai, China).

Techniques: Expressing, Control, Western Blot, Standard Deviation

Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of CCR2 + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).

Journal: Theranostics

Article Title: Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model

doi: 10.7150/thno.72289

Figure Lengend Snippet: Scaffold implantation modulates the systemic immune response post-MI, and cATMSC-EV promote a local effect. ( A-C ) Systemic analysis of the immune response post-MI. ( A ) The increase in the number of total peripheral blood mononuclear cells (PBMC) (left) and specifically in the number of lymphocytes (right) in whole blood that occurs 2 days after MI (red) is prevented by scaffold implantation. ( B ) The increase in the number of CCR2 + monocytes observed 30 days post-MI in untreated animals is blocked by scaffold implantation. ( C ) EV-Treated animals reduce the expression of CD73 in circulating monocytes 30 days from MI. Bars indicate mean ± SD and each data point corresponds to one animal (n = 4;7;8 respectively). Statistical significance was calculated with a paired Two-way ANOVA with Tukey's posthoc analysis. ( D-E ) Representative images ( D ) and quantification ( E ) of the number of infiltrating macrophages (CD163 + ; left), of which expressed CD73 (middle), and cells expressing CD73 (right) by immunohistofluorescence analysis at 30 days post-MI. Statistical significance was calculated with a One-way ANOVA with Tukey's posthoc analysis (Infarct core, left) and Student T-test (Scaffold, right). ( E ) CD163 (red), CD73 (green) and DAPI (blue).

Article Snippet: On one hand, 100 μL of whole blood were stained with the primary antibodies mouse anti-pig CD14-FITC (BioRad), anti-pig CD16-PE (BioRad), anti-human CCR2 (CD192)-PE-Vio770 (Miltenyi Biotech), rabbit anti-pig CD73 (Novus Biologicals) and mouse anti-pig CD163 (Novus Biologicals).

Techniques: Expressing, Immunohistofluorescence